Korean Market
PERI
Rznomics
★★★

Rznomics: FDA RMAT Designation and $1.9B Lilly Deal Highlight Pipeline Progress, Operating Loss Widens

 
EXCH
Rznomics
★

Holding Investor Relations Meeting via IBK-KOSDAQ Boom-Up Day